Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
1,543
Employees1,543
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
1,543
Employees1,543

NVAX Key Statistics

Market cap
1.34B
Market cap1.34B
Price-Earnings ratio
-3.56
Price-Earnings ratio-3.56
Dividend yield
Dividend yield
Average volume
7.28M
Average volume7.28M
High today
$8.38
High today$8.38
Low today
$7.97
Low today$7.97
Open price
$8.10
Open price$8.10
Volume
697.10K
Volume697.10K
52 Week high
$23.86
52 Week high$23.86
52 Week low
$3.53
52 Week low$3.53

NVAX News

TipRanks 2d
Novavax to Present at Jefferies London Conference

Don't Miss out on Research Tools: Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter inv...

Investor's Business Daily 7d
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?

Novavax (NVAX), a rival to Pfizer (PFE) and Moderna (MRNA), remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine,...

Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?

Analyst ratings

50%

of 6 ratings
Buy
50%
Hold
33.3%
Sell
16.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.